医学
肾脏疾病
心力衰竭
心脏病学
急性肾损伤
心肾综合症
内科学
心脏外科
重症监护医学
肾
作者
Anton Trask‐Marino,Bruno Marino,T. Lancefield,Emily See,Clive N. May,Lindsea C. Booth,Jai Raman,Yugeesh R. Lankadeva
出处
期刊:American Journal of Physiology-renal Physiology
[American Physical Society]
日期:2025-02-07
标识
DOI:10.1152/ajprenal.00266.2024
摘要
Chronic kidney disease (CKD) affects 50% of patients with heart failure. The pathophysiology of CKD in heart failure is proposed to be driven by macrocirculatory hemodynamic changes, including reduced cardiac output and elevated central venous pressure. However, our understanding of the renal microcirculation in heart failure and CKD remains limited. This is largely due to the lack of non-invasive techniques to assess the renal microcirculation in patients. Moreover, there is a lack of clinically relevant animal models of heart failure and CKD to advance our understanding of the timing and magnitude of renal microcirculatory dysfunction. Patients with heart failure and CKD commonly require cardiac surgery with cardiopulmonary bypass (CPB) to improve their prognosis. However, acute kidney injury (AKI) is a frequent unresolved clinical complication in these patients. There is emerging evidence that renal microcirculatory dysfunction, characterized by renal medullary hypoperfusion and hypoxia, plays a critical role in the pathogenesis of cardiac surgery-associated AKI. In this review, we consolidate the preclinical and clinical evidence of renal macro- and microcirculatory perturbations in heart failure and cardiac surgery requiring CPB. We also examine emerging biomarkers and therapies that may improve health outcomes for this vulnerable patient population by targeting the renal microcirculation.
科研通智能强力驱动
Strongly Powered by AbleSci AI